Figure: (Upper) Graphical abstract illustrating the concept of targeted alpha therapy using [211 At]NaAt in patients with radioactive iodine--refractory differentiated thyroid cancer (DTC). (Lower) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results